StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ACUT

AccuStem Sciences, Inc.

ACUT OTC Pharmaceutical Preparations EDGAR ↗
$0.21
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$3.37M
Revenue (TTM)
Net income (TTM)
-$1.80M
EPS (TTM)
$-0.12
P/E ratio
Dividend yield
Free cash flow
-$861K
Cash
Total assets
$1.55M
Gross margin
52-week range
$0.16 – $2.33

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-03-31 May 15, 2026 10-K Fiscal year ended 2025-12-31 Apr 14, 2026 8-K Other events Nov 26, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 20, 2025 10-K Fiscal year ended 2024-12-31 Apr 3, 2025 8-K/A Changed accountants Jan 2, 2025 8-K Changed accountants Dec 30, 2024 10-Q Quarter ended 2024-09-30 Nov 18, 2024 10-Q Quarter ended 2024-06-30 Sep 16, 2024 10-Q Quarter ended 2024-03-31 May 20, 2024 8-K Changed accountants Apr 10, 2024 10-K Fiscal year ended 2023-12-31 Mar 22, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Director or officer change Jun 9, 2023 8-K Regulation FD disclosure Jun 7, 2023 10-Q Quarter ended 2023-03-31 May 5, 2023 10-K/A Fiscal year ended 2022-12-31 Apr 28, 2023 10-K Fiscal year ended 2022-12-31 Feb 15, 2023 8-K Director or officer change Nov 16, 2022 10-Q Quarter ended 2022-09-30 Nov 8, 2022 8-K Shareholder vote results Oct 14, 2022 10-Q Quarter ended 2022-06-30 Aug 12, 2022 8-K Director or officer change Jun 21, 2022 10-Q Quarter ended 2022-03-31 May 20, 2022 10-K Fiscal year ended 2021-12-31 Apr 18, 2022 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Apr 5, 2022 8-K Director or officer change Mar 10, 2022 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Item 5.05; Other events Dec 3, 2021
Other filings
NT 10-K Mar 31, 2026 4 Jun 16, 2025 4 Jun 13, 2025 NT 10-Q May 15, 2025 4 Apr 10, 2025 4 Apr 8, 2025 NT 10-K Mar 31, 2025 SEC STAFF ACTION Feb 21, 2025 4 Jan 3, 2025